Intro
Chronic endometritis (CE) is a persistent inflammatory disease that is characterized by the
infiltration of plasma cells to the endometrial stroma
1
. Chronic endometritis is one of the major factors that account for the unexplained
infertility, in vitro fertilization (IVF) failure, and recurrent failure in
early pregnancy in women
2
. Antibiotic therapy is commonly used for the treatment of CE, but its efficacy is
unsatisfied. Therefore, developing novel strategies for the prevention and treatment of CE
is still needed.
Mesenchymal stem cells (MSCs) are a group of adult tissue progenitor cells that have the
potential of self-renewal and multilineage differentiation
3
. A recent study shows that transfer of endometrial mesenchymal stem cells (enMSCs)
meliorates CE and improves the repeated implantation failure
4
. Increasing evidence reveals that MSCs exert their function via transporting exosomes
(Exos), extracellular vesicles, as well as cytokines to host cells
5
. Exos are nanovesicles secreted by different cell types, which transfer proteins,
DNAs, and RNAs into the extracellular space and thus participate in a number of biological
processes, such as cell survival, immunity, and inflammation 6 – 8 . The use of Exos avoids a number of shortcomings of stem cell therapy
9
and thus is suggested to be an attractive approach for the treatment of multiple
diseases 10 , 11 .
Adipose tissue–derived stem cells (ADSCs) are mesenchymal cells derived from adipose
tissues, which possess the capacity of regenerative properties as MSCs
12
. A previous study reported that in dairy cows, treatment with bovine ADSCs inhibits
lipopolysaccharide (LPS)-induced inflammation response via suppressing the levels of tumor
necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) in
endometrial epithelial cells
13
. Multiple studies have reported that Exos derived from ADSCs play a crucial role in
the inhibition of inflammatory activity 14 – 16 . However, the therapeutic effect of Exos derived from ADSCs (ADSC-Exos)
on CE remains unknown.
In this study, we sought to investigate the effect of ADSC-Exos on LPS-induced inflammation
in endometrial cells both in vitro and in vivo , and
explore the possible mechanisms underlying their action.
Results
Exos were isolated by ultracentrifugation using the supernatant of ADSCs. The morphology
of Exos was analyzed using transmission electron microscopy and a spherical morphology was
detected ( Fig. 1A ). The mean size
distribution of Exos was 118.9 nm ( Fig.
1B ). Western blot was performed to detect the exosome makers, CD9 and CD63. As
shown in Fig. 1C , in comparison
with the control cells, the expressions of CD9 and CD63 were highly increased in Exos. We
then investigated whether Exos could be taken up by HESCs. Exos labeled with PKH67 green
fluorescent dye was incubated with HESCs for 24 h and immunofluorescence staining was
performed. As shown in Fig. 1D ,
green fluorescent spots were observed in HESCs, indicating that Exos were internalized by
HESCs.
Characterization of isolated exosomes (Exos) from ADSCs. (A) The morphology of Exos
was detected by TEM analysis. (B) Size distribution of Exos was indicated by
intensity. (C) The expression of exosome markers was analyzed by Western blot. (D) The
uptake of Exos by HESCs was accessed by immunofluorescence staining. ADSCs: adipose
tissue–derived stem cells; HESCs: human endometrial stromal cells; TEM: transmission
electron microscopy; DAPI:4’,6-diamidino-2-phenylindole.
To detect the function of Exos in CE, an in vitro CE model was
established by treating HESCs with LPS. The results showed that treatment with LPS reduced
the proliferation of HESCs ( Supplemental Fig. S1A ) and induced the expression of inflammatory factors,
such as IL-1β, IL-6, and TNF-α ( Supplemental Fig. S1B and C ). Interestingly, administration of Exos restored
the viability of HESCs inhibited by LPS ( Fig. 2A ). Moreover, while LPS increased the apoptosis of HESCs, treatment with
Exos blocked this effect ( Fig.
2B , C). In addition, cocultured with Exos decreased the mRNA and protein levels of
IL-1β, IL-6, and TNF-α that were induced by LPS in HESCs (Fig. 2D–G). Together, these
results indicate that Exos suppress LPS-mediated inflammation and increase HESC cell
proliferation.
Exos inhibit the LPS-induced inflammatory response in HESCs. (A) HESC proliferation
was detected by EdU staining following treatment with LPS alone or together with Exos.
(B) Apoptotic rate of HESCs was determined by flow cytometry following treatment with
LPS alone or together with Exos. (C) The expression of apoptosis-related proteins in
HESCs after treatment with LPS alone or together with Exos. (D–F) The mRNA expressions
of IL-1β (D), IL-6 (E), and TNF-α (F) were detected by qRT-PCR in HESCs following
treatment with LPS alone or together with Exos. (G) The protein expression of TNF-α,
IL-6, and IL-1β was detected by Western blot in HESCs following treatment with LPS
alone or together with Exos. LPS: lipopolysaccharide; HESCs: human endometrial stromal
cells; EdU: 5-ethynyl-2′-deoxyuridine; IL-1β: interleukin-1β; IL-6: interleukin-6;
TNF-α: tumor necrosis factor-alpha; qRT-PCR: quantitative real-time polymerase chain
reaction; GAPDH: glyceraldehyde-3-phosphate dehydrogenase;
DAPI:4’,6-diamidino-2-phenylindole.
miR-21 has been reported to be involved in LPS-induced inflammatory response in endometrium
17
. Therefore, we investigated whether miRNA-21 contributed to the inhibitory effect
of Exos on inflammation in our model. Quantitative real-time polymerase chain reaction
analysis showed that while LPS reduced the expression of miR-21 in HESCs, treatment with
Exos restored the level of miR-21 ( Fig.
3A ). To confirm the function of miR-21 in HESCs, EdU staining assay was carried
out. The result displayed that the number of EdU-positive cells was markedly decreased
after treatment with LPS, and this effect was counteracted by miR-21 ( Fig. 3B ). Lipopolysaccharide increased BAX
expression and decreased BCl-2 expression in HESCs, but these effects were reversed by
miR-21 ( Fig. 3C ), indicating that
miR-21 could repress LPS-induced HESC apoptosis. Moreover, overexpression of miR-21
decreased the levels of inflammatory cytokines, such as TNF-α, IL-6, and IL-1β, that were
elevated by LPS exposure ( Fig.
3D , E). Overall, these data indicate that Exos suppress LPS-stimulated inflammation
response and enhance HESC cell proliferation via miR-21.
Exos suppress LPS-stimulated inflammatory response via miR-21. (A) The expression of
miR-21 in HESCs was detected by qRT-PCR after treatment with LPS alone or together
with Exos. (B) The proliferation of HESCs was determined by EdU staining after
treatment with LPS alone or together with miR-21. (C) The expression of
apoptosis-associated proteins Bcl-2 and Bax was determined by Western blot after
treatment with LPS alone or together with miR-21. (D) The mRNA expression of TNF-α,
IL-6 and IL-1β was determined by qRT-PCR after treatment with LPS alone or together
with miR-21. (E) The mRNA expression of TNF-α, IL-6, and IL-1β was determined by
Western blot after treatment with LPS alone or together with miR-21. LPS:
lipopolysaccharide; HESCs: human endometrial stromal cells; qRT-PCR: quantitative
real-time polymerase chain reaction; EdU: 5-ethynyl-2′-deoxyuridine; TNF-α: tumor
necrosis factor-alpha; IL-6: interleukin-6; IL-1β: interleukin-1β; GAPDH:
glyceraldehyde-3-phosphate dehydrogenase; DAPI:4’,6-diamidino-2-phenylindole;
NC:negative control.
It is well known that TLR4 plays a key role in inflammation. TargetScan analysis revealed
that there was a miR-21-binding site in TLR4 3′-UTR ( Fig. 4A ). The luciferase reporter assay further
confirmed that TLR4 was a direct target of miR-21 in HESCs ( Fig. 4B ), which was consistent with previous studies
in other cell types 18 – 20 . Moreover, overexpression of miR-21
could effectively reduce TLR4 expression ( Supplemental Fig. S2 ). As shown in Fig. 4C , LPS increased TLR4 expression in HESCs, and
this effect was counteracted by Exo treatment. In agreement with this result,
administration of Exos decreased the phosphorylation of p65, a downstream effector of
TLR4, but not the total protein of p65 ( Fig. 4C ). In addition, while Exos reduced LPS-induced production of TNF-α, IL-6,
and IL-1β, overexpression of TLR4 abolished this effect ( Fig. 4D , E). Therefore, our data suggest that Exos
suppress LPS-induced inflammation via miR-21/TLR4/NF-κB signaling in HESCs.
Exos inhibit LPS-induced inflammatory response via miR-21/TLR4/NF-κB signaling. (A)
The potential binding site of miR-21 in TLR-4 3′-UTR was detected by TargetScan. (B)
The binding of miR-21 and TLR-4 3′-UTR was examined by dual-luciferase reporter assay.
(C) The expression levels of TLR4, p65, and p-p65 were examined by Western blot after
administration of LPS alone or together with Exos. (D) Overexpression of TLR4 reversed
the effect of Exos on LPS-induced mRNA expression of TNF-α, IL-6, and IL-1β in HESC.
(E) Overexpression of TLR4 reversed the effect of Exos on LPS-induced protein
expression of TNF-α, IL-6, and IL-1β in HESCs. LPS: lipopolysaccharide; TNF-α: tumor
necrosis factor-alpha; IL-6: interleukin-6; IL-1β: interleukin-1β; HESCs: human
endometrial stromal cells; GAPDH: glyceraldehyde-3-phosphate dehydrogenase;
TLR4:Toll-like receptor4; NF-KB:Nuclear factor kappa beta; UTR:Untranslated Region;
WT:wild type; MU:mutant; OE:overexpression.
To verify the effect of Exos on inflammatory activity, a CE mouse model was utilized.
Immunohistochemistry staining showed that the content of TNF-α, IL-6, and IL-1β was
significantly elevated in endometrial tissues of LPS-treated mice compared with the
control mice. However, co-administration of Exos reduced the production of these
inflammatory factors that were stimulated by LPS in endometrial tissues ( Fig. 5A ). Consistently, qRT-PCR and
Western blot validated that LPS induction markedly increased the mRNA and protein levels
of TNF-α, IL-6, and IL-1β, which was blocked by Exos in mouse endometrial tissues ( Fig. 5B , C). Collectively, these
results indicate that Exos have a protective activity against endometrial inflammation
in vivo .
Exos repress LPS-triggered inflammatory response in vivo . (A) The
protein levels of TNF-α, IL-6, and IL-1β in mouse endometrial tissues were detected by
immunohistochemical staining. (B) The mRNA levels of TNF-α, IL-6, and IL-1β in mouse
endometrial tissues were detected by qRT-PCR. (C) The protein levels of TNF-α, IL-6,
and IL-1β in mouse endometrial tissues were detected by Western blot. LPS:
lipopolysaccharide; TNF-α: tumor necrosis factor-alpha; IL-6: interleukin-6; IL-1β:
interleukin-1β; qRT-PCR: quantitative real-time polymerase chain reaction; GAPDH:
glyceraldehyde-3-phosphate dehydrogenase.
Discussion
Chronic endometritis is highly related to infertility in women. Hence, improving the
treatment of CE is of significant importance. In this study, we reported for the first time
that Exos derived from ADSCs had a suppressive effect on LPS-induced inflammation in
endometrial cells and in a mouse model.
Exos are small vesicle secreted by different cell types, including ADSCs
9
. ADSC-Exos have attracted more and more attention as potential therapeutic agent
21
. ADSC-Exos have been reported to possess an anti-inflammatory activity. For example,
Zhao et al.
14
report that Exos from ADSCs inhibit inflammation in white adipose tissue (WAT) of
diet-induced obese mice via activation of M2 macrophage polarization. Feng et al.
22
show that treatment with ADSC-Exos decreases the production of inflammatory factors
in microglia cells stimulated with LPS and thus prevent neuroinflammation. Chronic
endometritis is an inflammation disease in the inner layer of uterine mucosa
23
, which is mainly caused by microbial infection in the uterine cavity
24
. Lipopolysaccharide is one of the important causes of endometritis
25
. Therefore, an in vitro endometritis model was established by
treating HESCs with LPS. Using this model, we found that treatment with ADSC-Exos
significantly enhanced the proliferation of HESCs and inhibited HESC apoptosis. More
importantly, we found ADSC-Exos decreased the expression levels of IL-1β, TNF-α, and IL-6
stimulated by LPS, indicating that ADSC-Exos had a protective activity against LPS-induced
inflammation. Moreover, the anti-inflammatory activity of ADSC-Exos was also verified by a
mouse model. Therefore, our data indicate that ADSC-Exos have a protective activity against
LPS-induced inflammation in endometrial cells both in vitro and in
vivo .
It has been demonstrated that Exos can deliver different biomolecules to target cells to
exert their function 6 – 8 . Among these cargo molecules, miRNAs have
attracted great attention due to their extensive regulation in gene expression
26
. The function of miR-21 in inflammation modulation has been documented
previously 27 – 29 . It has been shown that in equine
endometrium, the expression of miR-21 is markedly decreased after LPS challenge, indicating
an involvement of miR-21 in inflammatory response in endometrium
17
. Consistently, our work showed that LPS exposure reduced the level of miR-21 in
HESCs, whereas administration of ADSC-Exos restored the expression of miR-21. Moreover,
overexpression of miR-21 caused downregulation of inflammatory cytokines, including IL-1β,
TNF-α, and IL-6, and increased HESC proliferation. Therefore, our results suggest that
miR-21 plays an important role in ADSC-Exo-mediated suppression of inflammation
response.
Toll-like receptor (TLR) is critical for the primary innate immune response to pathogenic challenge
30
. Studies from Ju et al.
31
reveal that TLR4 plays a critical role in the pathogenesis of human CE. They found
that the expression of TLR4, as well as the levels of its corresponding downstream signaling
factors, such as p-p65, TNF-α, and IL-1β, is upregulated in CE tissues compared with normal
endometrial tissues
31
. miR-21 has been shown to regulate TLR4 expression 18 – 20 . It has been reported that overexpression of miR-21 inactivates
TLR4/NF-kB pathway and thus suppresses myocardial apoptosis
18
. In our experiments, we found that TLR4 expression was downregulated by miR-21 and
luciferase reporter assay confirmed that TLR4 was a direct target of miR-21 in endometrial
cells. In addition, treatment with Exos decreased the expression of TLR4, as well as the
phosphorylation of p65, a downstream factor of TLR4. In addition, administration of
ADSC-Exos reduced the secretion of LPS-induced IL-1β, TNF-α, and IL-6, but this effect was
blocked by ectopic expression of TLR4. Taken together, our results indicate the ADSC-Exos
attenuates LPS-induced inflammation via miR-21/TLR4/Nf-κB signaling. In summary, this study
reveals that ADSC-derived Exos have an inhibitory effect on LPS-stimulated inflammation in
endometrial cells both in vitro and in vivo , which is
mediated by the regulation of miR-21/TLR4/Nf-κB signaling pathway. Our results suggest that
Exos-based therapy may be a promising strategy for the treatment of inflammation-associated
diseases, including CE.
Materials|Methods
Human endometrial stromal cells (HESCs) and human ADSCs were obtained from the American
Type Culture Collection (ATCC, USA) and Cyagen Biology (Guangzhou, China), respectively.
Human endometrial stromal cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM)/F12 (Thermo Fisher Scientific, Waltham, MA, USA), which contains 2% fetal bovine
serum (FBS; Thermo Fisher Scientific) and 1% penicillin-streptomycin (Thermo Fisher
Scientific), while ADSCs were cultured in DMEM medium (Thermo Fisher Scientific) that
contains 10% FBS and 1% penicillin-streptomycin. Both HESCs and ADSCs were maintained at
37°C in an incubator with 5% CO 2 .
Exosome extraction was carried out with the medium of ADSCs by ultracentrifugation. The
centrifugation of medium was performed as follows: 3,000 × g for 15 min
and then 20,000 × g for 45 min at 4°C. The supernatant was collected and
filtered. Then, the supernatant was centrifuged again at 110,000 × g for
70 min at 4°C twice. The exosome pellet was resuspended with phosphate-buffered saline
(PBS) and stored at −80°C for further experiments.
Transmission electron microscopy was used to visualize the morphology of isolated Exos. A
drop of Exos in PBS solution was placed onto a copper grid. Exos were washed with PBS and
then fixed with glutaraldehyde solution (3%) for 15 min. After another wash with PBS, Exos
were incubated with uranyl acetate solution (2%) for 5 min. Finally, Exos were visualized
using a transmission electron microscope and the Exo size was measured using a dynamic
light scattering.
To analyze whether Exos could be taken up by HESCs, Exos were firstly labeled with KH67
fluorescent dye (Sigma-Aldrich, St. Louis, MO, USA). Then, 2 μg KH67-labeled Exos were
added to HESCs that were cultured in 6-well plates. Twenty-four hours later, HESCs were
fixed with 4% paraformaldehyde and stained with 4′,6-diamidino-2-phenylindole solution.
The staining of HESCs was examined using a confocal microscope (Carl Zeiss, Oberkochen,
Germany).
The EdU (5-ethynyl-2′-deoxyuridine) staining assay was performed to detect the
proliferation of HESCs. Human endometrial stromal cells (5 × 10 4 ) were seeded
in a 24-well plate and cultured overnight. 500 ng/ml LPS (Sigma-Aldrich) and/or 1 μg Exos
were added onto HESCs. Twenty-four hours later, HESCs were washed with PBS once and
stained with the BeyoClick™ EdU-488 Cell Proliferation Assay Kit (Beyotime, Shanghai,
China), according to the manufacturer’s instructions. DNA staining was performed with DAPI
solution. Human endometrial stromal cells were visualized using a fluorescence
microscopy.
To detect the direct interaction between miR-21 and TLR4, luciferase reporter assay was
conducted. TRL4 3′-untranslated region fragments with wild-type or mutant miR-21 binding
site were cloned into the luciferase reporter vector to construct TRL4 wild type
3′-untranslated region or TRL4 MU 3′-untranslated region. Human endometrial stromal cells
were co-transfected with TRL4 wild type 3′-UTR (or TRL4 mutant 3′-untranslated region) and
miR-21 (or control miRNA) using the Lipofectamine 2000 reagent (Invitrogen, CA, USA).
After transfection for 48 h, the firefly and renilla luciferase activity were detected
with the dual-luciferase reporter assay kit (Promega, Madison, WI, USA), according to the
manufacturer’s protocol.
Flow cytometry was performed to analyze the apoptotic rate of HESCs. Human endometrial
stromal cells (2.5 × 105 cells/well) were cultured in 6-well plates overnight before
treatment. Human endometrial stromal cells were treated with 500 ng/ml LPS alone or
together with 1 μg Exos for 48 h. Then, the medium was removed and HESCs were collected.
After centrifugation, the cell pellet was washed with PBS once. Staining of HESCs was
conducted using the Annexin V-FITC apoptosis detection kit (BD, Franklin Lakes, NJ, USA)
following the manufacturer’s introduction. Stained cells were analyzed using the flow
cytometer (BD Biosciences).
Cell Counting Kit-8 assay was carried out to determine the viability of HESCs. HESCs were
seeded in a 96-well plate and treated with different concentrations of LPS (0–500 ng/ml)
for 48 h. At the indicated time point, 10 μl of Cell Counting Kit-8 solution (Seyotin,
Guangzhou, China) was added to each well and the cells were incubated for 2–4 h. Finally,
the optical density (OD) at 450 nm was examined by a microplate reader (BioTek, Vermont,
USA).
Total RNA from HESCs or endometrial tissues was isolated using the Trizol reagent (Thermo
Fisher Scientific). Complementary DNA (cDNA) synthesis was performed with total RNA using
the Invitrogen TM Superscript III First-Strand Synthesis System (Seyotin). For the
detection of miR-21, cDNA was reversed using a TaqMan™ Advanced miRNA cDNA Synthesis Kit
(Seyotin). Real-time polymerase chain reaction (PCR) was carried out using the PowerUp
SYBR Green PCR Master Mix (Seyotin). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
used as an internal control for mRNA expression and U6 was used as an internal control of
miR-21 expression. Relative gene expression levels were measured using a 2 –ΔΔCT
formula. The primers used were as follows: TLR4-F, ACTTGGACCTTTCCAGCAAC and TLR4-R,
TTTAAATGCACCTGGTTGGA; TNF-α-F, TGACGGGCTTTACCTCATCT and TNF-α-R, TGATGGCAGACAGG ATGTTG;
IL-6-F, AACGAGTGGGTAAAGAACGC and IL-6-R, CTGACCAGA GGAGGGAATGC; β-actin-F,
CCAAGGCCAACCGTGA GAAAAT and β-actin-R, CCACATTCCGTGAGGATCTTCA; IL-1β-F, ATGAAG
AGCTGCATCCAACA and IL-1β-R, ATGGAAGACATGTGCGTAGG.
HESCs and Exos were collected, washed with PBS, and lysed in radioimmunoprecipitation
assay (RIPA) lysis buffer. The concentration of different samples was detected by the
bicinchoninic acid method. The protein sample was separated by 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel, followed by transfer onto a
polyvinylidene fluoride (PVDF) membrane (Seyotin). The membrane was incubated with TBST
(TBS-Tween 20) solution containing 5% non-fat milk for 1 h at room temperature. Then, the
membrane was incubated with primary antibodies at 4°C overnight. On the next day, the
membrane was washed three times with PBS and incubated with horseradish peroxidase
(HRP)-conjugated secondary antibodies for 90 min at room temperature. Protein bands were
visualized using the ECL Western Blotting Substrate (Seyotin). The used antibodies were as
follows: CD9, 1:1,000, ab92726, Abcam; CD63, 1:1,000, ab134045, Abcam; TNF-α, 1:1,000,
17590-1-AP, Proteintech; IL-1β1:1,000, #12242, Cell Signaling Technology; IL-6, 1:1,000,
ab6672, Abcam; GAPDH 1:2,000, 60004-1-Ig, Proteintech; TLR4, 1:1,000, ab13556, Abcam;
p-p65, 1:1,000, #3033, Cell Signaling Technology; p65, 1:1,000, #8242, Cell Signaling
Technology.
PCDNA3.1-Myc-TLR4 overexpressing plasmid was purchased from Genecopoeia. DNA transfection
was carried out using the Lipofectamine™ 3000 reagent (Thermo Fisher Scientific).
A CE mouse model was established to detect the function of Exos in the inflammation
response in vivo . Kunming female mice (8–10 weeks old, 25–30 g) were
purchased from the Chinese Academy of Sciences (Beijing, China) and cultured under a 12 h
light/12 h dark cycle. The mice were randomly divided into three groups with 10 mice per
group (control, LPS, and Exos). The control group received 20 μl of PBS by uterine
perfusion, while the LPS group received 20 μl of LPS (2.5 μg/μl). Twelve hours
post-perfusion, mice in the control and LPS groups were intraperitoneally injected with 20
μl of PBS, and mice in the Exos group were intraperitoneally injected with 20 μg of
exosomes. Twelve hours later, mice were sacrificed and the uteri were isolated for further
experiments. All animal procedures were conducted according to the animal guidelines
approved by the Institutional Animal Care and Use Committee of Daoke Medical Technology
(Guangdong) Co., LTD.
Mouse endometrial tissues were fixed in 10% buffered formalin and embedded in paraffin.
Paraffin-embedded tissues were cut into 4-μm-thick sections. Sections were then dewaxed,
dehydrated, and antigen-retrieved in citrate buffer. After blocking in 5% bovine serum
albumin, sections were probed with TNF-α, IL-1β, and IL-6 antibodies. Sections were washed
three times with PBS and incubated with biotinylated secondary antibody. After three
washes with PBS, sections were incubated with HRP-conjugated streptavidin (Thermo Fisher
Scientific), followed by incubation with diaminobenzidine solution. Sections were
counterstained with hematoxylin.
Data were represented as mean ± standard deviation (SD). Statistical analysis was carried
out using the SPSS 15.0 software (SPSS, USA). Comparisons among different groups were
accessed by one-way analysis of variance (ANOVA). Values of P < 0.05
were considered statistically significant.
Supplementary Material
Click here for additional data file.
Supplemental material, sj-jpg-1-cll-10.1177_09636897231173736 for Exosomes From
Adipose-Derived Stem Cells Suppress the Progression of Chronic Endometritis by Bin Wang,
Li Li and Ruizhu Yu in Cell Transplantation
Click here for additional data file.
Supplemental material, sj-jpg-2-cll-10.1177_09636897231173736 for Exosomes From
Adipose-Derived Stem Cells Suppress the Progression of Chronic Endometritis by Bin Wang,
Li Li and Ruizhu Yu in Cell Transplantation
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.